MetLife Investment Management’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $575K | Hold |
43,883
| – | – | ﹤0.01% | 1607 |
|
|
2025
Q1 | $965K | Sell |
43,883
-729
| -2% | -$16K | 0.01% | 1387 |
|
|
2024
Q4 | $1.19M | Buy |
44,612
+2,341
| +6% | +$62.5K | 0.01% | 1323 |
|
|
2024
Q3 | $1.13M | Hold |
42,271
| – | – | 0.01% | 1327 |
|
|
2024
Q2 | $761K | Buy |
42,271
+12,336
| +41% | +$222K | ﹤0.01% | 1500 |
|
|
2024
Q1 | $546K | Buy |
29,935
+6,580
| +28% | +$120K | ﹤0.01% | 1626 |
|
|
2023
Q4 | $256K | Hold |
23,355
| – | – | ﹤0.01% | 2094 |
|
|
2023
Q3 | $134K | Hold |
23,355
| – | – | ﹤0.01% | 2430 |
|
|
2023
Q2 | $181K | Hold |
23,355
| – | – | ﹤0.01% | 2340 |
|
|
2023
Q1 | $156K | Hold |
23,355
| – | – | ﹤0.01% | 2363 |
|
|
2022
Q4 | $209K | Hold |
23,355
| – | – | ﹤0.01% | 2223 |
|
|
2022
Q3 | $230K | Hold |
23,355
| – | – | ﹤0.01% | 2202 |
|
|
2022
Q2 | $186K | Hold |
23,355
| – | – | ﹤0.01% | 2376 |
|
|
2022
Q1 | $227K | Buy |
23,355
+8,328
| +55% | +$80.8K | ﹤0.01% | 2281 |
|
|
2021
Q4 | $230K | Buy |
+15,027
| New | +$230K | ﹤0.01% | 1968 |
|